Casdin Capital, LLC 13D and 13G filings for Magenta Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-13 9:31 pm Sale |
2022-12-31 | 13G | Magenta Therapeutics, Inc. MGTA |
Casdin Capital, LLC | 0 0.000% |
-3,901,589 (Position Closed) |
Filing |
| 2022-02-11 10:00 pm Purchase |
2021-12-31 | 13G | Magenta Therapeutics, Inc. MGTA |
Casdin Capital, LLC | 3,901,589 6.640% |
555,554 (+16.60%) |
Filing |
| 2021-02-11 10:25 am Purchase |
2020-12-31 | 13G | Magenta Therapeutics, Inc. MGTA |
Casdin Capital, LLC | 3,346,035 6.930% |
247,913 (+8.00%) |
Filing |